Skip to main content
ABSTRACT & COMMENTARY

Intravenous Glyburide to Reduce Brain Swelling in Large Hemispheric Infarction

In a Phase II, randomized, multicenter prospective trial, intravenous glyburide failed to improve outcomes in patients with large hemispheric infarction, although there was a reduction in neuroimaging and biomarkers of cerebral edema.